相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalized Management of Pheochromocytoma and Paraganglioma
Svenja Noelting et al.
ENDOCRINE REVIEWS (2022)
Single nucleotide polymorphisms in matrix metalloproteinase 2 (MMP2) enhance BRAFV600E mutation-mediated oncogenicity and invasiveness of papillary thyroid cancer cells
Avaniyapuram Kannan Murugan et al.
ENDOCRINE-RELATED CANCER (2021)
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
Shahida K. Flores et al.
CANCERS (2021)
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
Alexandre Buffet et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Identification and characterization of two novel oncogenic mTOR mutations
Avaniyapuram Kannan Murugan et al.
ONCOGENE (2019)
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
Ying Pang et al.
CANCERS (2019)
Pheochromocytoma and Paraganglioma
Hartmut P. H. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
Federica Panebianco et al.
CANCER MEDICINE (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
Evolving Understanding of the Epidemiology of Thyroid Cancer
Carolyn Dacey Seib et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)
A Family With a Carotid Body Paraganglioma and Thyroid Neoplasias With a New SDHAF2 Germline Variant
Katherine Wolf et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect
Po-Lin Tseng et al.
SCIENTIFIC REPORTS (2018)
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
Haoyu Ren et al.
CANCER MANAGEMENT AND RESEARCH (2018)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
Bryan R. Haugen
CANCER (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
TERT promoter mutations in thyroid cancer
Rengyun Liu et al.
ENDOCRINE-RELATED CANCER (2016)
TERT Promoter Mutations in Thyroid Cancer
Ali S. Alzahrani et al.
HORMONES & CANCER (2016)
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prognostic Value of Genetic Mutations in Thyroid Cancer: A Meta-Analysis
Kyoungjune Pak et al.
THYROID (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
Tiantian Liu et al.
ENDOCRINE-RELATED CANCER (2014)
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
Thomas G. Papathomas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function
Chunzhang Yang et al.
FASEB JOURNAL (2012)
Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53
Ying Ni et al.
HUMAN MOLECULAR GENETICS (2012)
Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis
Leonie Theresia van Hulsteijn et al.
JOURNAL OF MEDICAL GENETICS (2012)
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
R. Michael Tuttle et al.
THYROID (2010)
Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes
Ying Ni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
SWAP-70 is important for invasive phenotypes of mouse embryo fibroblasts transformed by v-src
Avaniyapuram Kannan Murugan et al.
IUBMB LIFE (2008)
BRAF mutation in papillary thyroid carcinoma
J Cohen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
